NovoCure (NVCR) Operating Margin Growth (1y) (2015 - 2026)
Powered by 
Analysis
NovoCure (NVCR) Operating Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn | 146.00 |
| 10 | NovoCure | 1.90 Bn | 1.46 Bn | 142.48 Mn | 1,913.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,913.00 |
| Mar 31, 2026 | -1,430.00 |
| Dec 31, 2025 | 1,609.00 |
| Sep 30, 2025 | -85.00 |
| Jun 30, 2025 | -255.00 |
| Mar 31, 2025 | 555.00 |
| Dec 31, 2024 | -60.00 |
| Sep 30, 2024 | 2,505.00 |
| Jun 30, 2024 | 2,738.00 |
| Mar 31, 2024 | 1,933.00 |
| Dec 31, 2023 | -519.00 |
| Sep 30, 2023 | -2,696.00 |
| Jun 30, 2023 | -3,471.00 |
| Mar 31, 2023 | -4,872.00 |
| Dec 31, 2022 | -1,590.00 |
| Sep 30, 2022 | -1,239.00 |
| Jun 30, 2022 | -579.00 |
| Mar 31, 2022 | -52.00 |
| Dec 31, 2021 | -2,596.00 |
| Sep 30, 2021 | -1,772.00 |